Insider Transactions
| Date | Name | Title | Filing | Type | Shares Traded | Price Range | Total Held |
|---|---|---|---|---|---|---|---|
| Jul 19, 2023 | SVP Global Operations and R&D | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 21,578 | -- | 21,578 | |
| Jul 26, 2017 | EVP and CFO | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 21,762 | -- | 21,762 | |
| Jul 19, 2023 | SVP/GM, VIT | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 21,913 | -- | 21,913 | |
| Jul 26, 2017 | Director, President and CEO | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 22,092 | -- | 113,775 | |
| Jul 14, 2020 | SVP Global Operations and R&D | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 22,196 | -- | 22,196 | |
| Aug 17, 2012 | Director, President and CEO | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 22,247 | -- | 63,097 | |
| Jul 18, 2018 | EVP and CFO | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 22,260 | -- | 22,260 | |
| Jul 19, 2023 | SVP Global Operations and R&D | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 22,329 | -- | 22,329 | |
| Jul 19, 2023 | SVP/GM, Vascular Access | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 22,768 | -- | 22,768 | |
| Jul 19, 2023 | SVP/GM, Vascular Access | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 23,561 | -- | 23,561 |
For recent transactions, including derivative transactions, see our Section 16 SEC filings page.